Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0WN9P
|
||||
Former ID |
DNC011035
|
||||
Drug Name |
4'-(Pyridin-4-ylmethyl)biphenyl-3-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531085] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H16N2
|
||||
Canonical SMILES |
C1=CC(=CC(=C1)N)C2=CC=C(C=C2)CC3=CC=NC=C3
|
||||
InChI |
1S/C18H16N2/c19-18-3-1-2-17(13-18)16-6-4-14(5-7-16)12-15-8-10-20-11-9-15/h1-11,13H,12,19H2
|
||||
InChIKey |
MVDKLMQNQSJYHJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [531085] | |
17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [531085] | ||
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [531085] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
WikiPathways | Metapathway biotransformation | ||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Ovarian Infertility Genes | |||||
Metabolism of steroid hormones and vitamin D | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Steroid Biosynthesis | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.